Impact of the COVID‑19 pandemic on acute pancreatitis in the
Czech Republic: pilot data from the PANACOTA (pancreatitisacuta
in COVID time analysis) study

a 2023

Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study

HARAZIM, Martin a Radek KROUPA

Základní údaje

Originální název

Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study

Autoři

HARAZIM, Martin a Radek KROUPA

Vydání

42nd International Symposium on Intensive Care & Emergency Medicine, 2023

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Belgie

Utajení

není předmětem státního či obchodního tajemství

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

acute pancreatitis; COVID-19; surgery; endoscopic drainage; complications; epidemiology

Změněno: 5. 4. 2024 10:10, Mgr. Tereza Miškechová

Anotace

V originále

healthcare. Acute pancreatitis (AP) is a clinically serious disease that almost always requires hospitalisation and treatment that cannot be delayed or planned. International studies have highlighted the potential negative impact of COVID-19 infection on the onset and severity of the disease. The aim of this study is to analyse the impact of the COVID-19 pandemic on the epidemiology, treatment and prognosis of acute pancreatitis at the population level. Methods: Comparison of parameters of hospitalizations for acute pancreatitis, care provided and treatment outcomes during the pandemic (2020 + 2021) with previous years (2010–2019) using data from the National Registry of Covered Health Services. Presentation of pilot data. Results: Hospitalizations for AP increased slightly from 2010 to 2015 to about 7000/year with a relatively stationary number in 2016– 2021. Hospitalizations for AP in each month of 2020 and 2021 did not correlate with the number of COVID-19 positive patients and showed a similar trend (with peaks in summer and at the end of the year) as in the years prior to the pandemic. Concurrently with AP, 2.3% and 3.7% of patients had COVID-19 infection in 2020 and 2021, respectively. AP mortality in the pre-pandemic and pandemic years was virtually the same at 3.9%. There was no difference in length of hospital or ICU stay. There was a downward trend in the number of ERCPs and surgical interventions performed. Conclusions: According to pilot population data, the COVID-19 pandemic did not have an impact on the incidence or prognosis of acute pancreatitis in the Czech Republic. Changes in trends in interventions performed correlate with recent expert recommendations and are unlikely to be related to the reduction in care due to the pandemic.

Citovat

HARAZIM, Martin a Radek KROUPA. Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study. In 42nd International Symposium on Intensive Care & Emergency Medicine. 2023.

@proceedings{2360058,
   author = {Harazim, Martin and Kroupa, Radek},
   booktitle = {42nd International Symposium on Intensive Care & Emergency Medicine},
   keywords = {acute pancreatitis; COVID-19; surgery; endoscopic drainage; complications; epidemiology},
   language = {eng},
   title = {Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study},
   year = {2023}
}

TY  - CONF
ID  - 2360058
AU  - Harazim, Martin - Kroupa, Radek
PY  - 2023
TI  - Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study
KW  - acute pancreatitis
KW  - COVID-19
KW  - surgery
KW  - endoscopic drainage
KW  - complications
KW  - epidemiology
N2  - healthcare. Acute pancreatitis (AP) is a clinically serious disease that almost always requires hospitalisation and treatment that cannot be delayed or planned. International studies have highlighted the potential negative impact of COVID-19 infection on the onset and severity of the disease. The aim of this study is to analyse the impact of the COVID-19 pandemic on the epidemiology, treatment and prognosis of acute pancreatitis at the population level. Methods: Comparison of parameters of hospitalizations for acute pancreatitis, care provided and treatment outcomes during the pandemic (2020 + 2021) with previous years (2010–2019) using data from the National Registry of Covered Health Services. Presentation of pilot data. Results: Hospitalizations for AP increased slightly from 2010 to 2015 to about 7000/year with a relatively stationary number in 2016– 2021. Hospitalizations for AP in each month of 2020 and 2021 did not correlate with the number of COVID-19 positive patients and showed a similar trend (with peaks in summer and at the end of the year) as in the years prior to the pandemic. Concurrently with AP, 2.3% and 3.7% of patients had COVID-19 infection in 2020 and 2021, respectively. AP mortality in the pre-pandemic and pandemic years was virtually the same at 3.9%. There was no difference in length of hospital or ICU stay. There was a downward trend in the number of ERCPs and surgical interventions performed. Conclusions: According to pilot population data, the COVID-19 pandemic did not have an impact on the incidence or prognosis of acute pancreatitis in the Czech Republic. Changes in trends in interventions performed correlate with recent expert recommendations and are unlikely to be related to the reduction in care due to the pandemic.
ER  -

HARAZIM, Martin a Radek KROUPA. Impact of the COVID‑19 pandemic on acute pancreatitis in the Czech Republic: pilot data from the PANACOTA (pancreatitisacuta in COVID time analysis) study. In \textit{42nd International Symposium on~Intensive Care \&{} Emergency Medicine}. 2023.

Podrobný výpis o publikaci